This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Health product recall

Haloperidol Inj 5mg/ml USP (2017-07-17)

Starting date:
July 17, 2017
Posting date:
October 4, 2017
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-64616

Affected products

Haloperidol Inj 5mg/ml USP

Reason

Affected product was stored outside of the recommended storage conditions.

Depth of distribution

Retail stores/pharmacies in Manitoba, Saskatchewan, Alberta and Ontario

Affected products

Haloperidol Inj 5mg/ml USP

DIN, NPN, DIN-HIM

0808652

Dosage form

Liquid

Strength

5mg/ml

Lot or serial number

EXP 11/2018

Product UPC

UPC 057513029004

Companies
Recalling Firm

Kohl & Frisch Limited (Distributor)

1750 Inkster Boulevard

Winnipeg

R2X IR4

Manitoba

CANADA

Marketing Authorization Holder

Sandoz Canada Incorporated

145 Jules Léger Street

Boucherville Québec

J4B 7K8

Quebec

CANADA